Delivery Order SPE2DB22D3501-SPE2DB25FXN85
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,571.07 to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Kerendia 10 mg tablets (30-count packaging). This is a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Kerendia 10 mg tablets (30-count packages) with a ceiling value of $1,529.00. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a $5,211.66 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Kerendia 10 mg tablets (90-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $15,518.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Kerendia 20 mg on September 12, 2025, with completion targeted for September 15, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime contractor, headquartered in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,593.24 on August 20, 2025, for the supply of Kerendia 10 mg tablets (30-count packages). This firm fixed-price, non-set-aside contract is scheduled for completion by August 21, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. Kerendia is a prescription medication used in the treatment of chronic kidney disease, representing the type of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 30, 2025, for the supply of Kerendia 20 mg tablets (30-count packaging) with a ceiling value of $10,329.51. This firm fixed price delivery order, which represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, is scheduled for completion by September 2, 2025. The award was competitively awarded with no set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Kerendia 10 mg tablets (30-count) with a ceiling value of $7,855.53. This firm fixed-price delivery order, with an ultimate completion date of June 20, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $17,656.81 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count units) under a firm fixed price contract. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Kerendia 10 mg tablets (90-count units) with a ceiling value of $6,552.19. This is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and is classified as a non-set-aside contract, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Kerendia 10 mg tablets (30-count packages) under a firm fixed-price contract with a ceiling value of $2,409.10. This non-set-aside award represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999 through December 2026. The prime...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXN85Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Kerendia 10 mg tablets (30-count packages) valued at $3,603.95. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is scheduled for completion by September 29, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is well-positioned to fulfill federal medical procurement requirements through its extensive portfolio of brand-name and generic medications, vaccines, and medical devices. The company holds a significant relationship with the Defense Logistics Agency's Medical Supply Chain and serves multiple federal healthcare customers including the Defense Health Agency and U.S. Coast Guard. Kerendia is a cardiovascular and renal protective medication used in the treatment of chronic kidney disease, reflecting the breadth of therapeutic domains AmerisourceBergen supplies to support military and federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 9/26/25 |